Skip to content
buyModerate cluster of 2

George M Jenkins bought $500k of PVLA

director at PALVELLA THERAPEUTICS, INC.. 4,000 shares at an average of $125.00, traded Feb 27, 2026, filed Mar 2, 2026.

Conviction score
41
Value
$500k
4,000 shares
Holdings after
187,171
+2% from before
From 52-week low
+616%
low $18.85, close $135.02
From 52-week high
-9%
high $148.34, as of Feb 27, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $500k at market
    +18
  • Relative to holdings
    Holdings up 2.2%
    0
  • Price context
    Near the top of the 52-week range
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -9.2%, 3m -15.1%, 6m +15.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

PVLAOct 12, 2026 · close 134.38
Since filing Mar 2, 2026: +1.3%SPY +14.2% · excess -12.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-26-021922, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 27, 2026POpen-market purchase
Common Stock
+4,000$125.00$500k187,171Mar 2, 2026

Related signals

Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
PVLAsell 310b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$655k
4,302 shares
-100%
40Moderate
PVLAsell 310b5-1
PALVELLA THERAPEUTICS, INC.
George M Jenkins
director
$4.2M
27,500 shares
-15%
42Moderate
PVLAsell 3
PALVELLA THERAPEUTICS, INC.
Christopher P Kiritsy
director
$49k
313 shares
-56%
33Weak
PVLAsell 210b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$655k
4,302 shares
-100%
25Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$642k
4,302 shares
-100%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$476k
4,302 shares
-100%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$476k
4,302 shares
-100%
24Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$547k
4,302 shares
-100%
26Weak
PVLAbuy
PALVELLA THERAPEUTICS, INC.
George M Jenkins
director
$50k
445 shares
+0%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$508k
4,302 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

George M Jenkins bought $500k of PVLA | InsiderTell